RNTX
Rein Therapeutics, Inc.
0.78
USD
This page is just a preview of the data found in TrendSpider’s full version
Fundamentals
Fundamental data refers to the information about the company itself, its financial state, sales and revenues, profitability and growth. This is a set of metrics used by financial analysts to gauge the financial health of an organization as well as its future prospects. This page will include information about many of the common fundamental metrics and KPIs used to evaluate and price the value of public corporations in the United States and around the world.
Market-Cap
89.20M USD
Enterprise Value
80.66M USD
Price to Earnings Ratio (ttm)
-0.6
EV/EBITDA
-1.6
Net Income
-6.38M USD
Earnings Per Share, Basic
-0.10 USD
Earnings Per Share, Diluted
-0.10 USD
EBITDA
-6.08M USD
Shares (Basic)
67,084,661.00
Shares (Diluted)
67,084,661.00
Price to Sales Ratio (ttm)
0.0
Price to Book Value
0.0
Revenue
0.00 USD
Cost of Revenue
0.00 USD
Gross Profit
0.00 USD
Operating Expenses
0.00 USD
Join Our Market Watch Newsletter!
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!